HUM Stock Down -9.3% after 6-Day Loss Streak
Humana (HUM) stock hit day 6 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -9.3% return. The company has lost about $2.8 Bil in value over the last 6 days, with its current market capitalization at about $30 Bil. The stock remains 0.3% above its value at the end of 2024. This compares with year-to-date returns of 13.3% for the S&P 500.
HUM provides medical benefit plans through Retail, Group and Specialty, and Healthcare Services segments, serving approximately 17 million members as of December 31, 2021. Is this drop a warning sign or a setup for rebound? Deep dive with Buy or Sell HUM.
Comparing HUM Stock Returns With The S&P 500
The following table summarizes the return for HUM stock vs. the S&P 500 index over different periods, including the current streak:
- What Could Rocket Alphabet Stock to New Heights
- The Hidden Dangers Facing Micron Technology Stock
- Cash Machine Trading Cheap – Docusign Stock Set to Run?
- Micron Technology Stock On A Winning Streak: Time To Get In Or Book Profits?
- Is Microsoft Stock Poised for a Rally?
- With Strong Cash Flow, Constellation Brands Stock Poised to Rise?
| Return Period | HUM | S&P 500 |
|---|---|---|
| 1D | -4.6% | 0.5% |
| 6D (Current Streak) | -9.3% | 1.2% |
| 1M (21D) | -12.9% | 4.2% |
| 3M (63D) | 5.4% | 11.7% |
| YTD 2025 | 0.3% | 13.3% |
| 2024 | -44.0% | 23.3% |
| 2023 | -9.9% | 24.2% |
| 2022 | 11.2% | -19.4% |
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact. Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: HUM Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 77 S&P constituents with 3 days or more of consecutive gains and 47 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 55 | 22 |
| 4D | 12 | 8 |
| 5D | 7 | 2 |
| 6D | 0 | 14 |
| 7D or more | 3 | 1 |
| Total >=3 D | 77 | 47 |
Key Financials for Humana (HUM)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $106.4 Bil | $117.8 Bil |
| EBT | $3.4 Bil | $1.7 Bil |
| Net Income | $2.5 Bil | $1.2 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $32.1 Bil | $32.4 Bil |
| EBT | $1.7 Bil | $741.0 Mil |
| Net Income | $1.2 Bil | $545.0 Mil |
The losing streak HUM stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.